IP Verse

Hexal Pharma competitive analysis

Loading summary...

Explore patent oppositions filed by Hexal Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3024461	A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial Translocation	EURO CELTIQUE	May 14, 2020
EP2941251	Crenolanib For Treating Flt3 Mutated Proliferative Disorders	AROG PHARMACEUTICALS	Dec 7, 2018

Explore the latest publications and patents granted to Hexal Pharma, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Hexal Pharma, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Hexal Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
HEXAL PHARMA	2	-	-	-
AROG PHARMACEUTICALS	-	1	-	-
EURO CELTIQUE	-	44	-	-